ATE184485T1 - Verwendung der 1-4-4-aryl(oder heteroaryl)-1- piperazinylbutyl-1h-azol-derivate zur herstellung von arzneimitteln zur behandlung der störungen der magensekretion - Google Patents

Verwendung der 1-4-4-aryl(oder heteroaryl)-1- piperazinylbutyl-1h-azol-derivate zur herstellung von arzneimitteln zur behandlung der störungen der magensekretion

Info

Publication number
ATE184485T1
ATE184485T1 AT94402673T AT94402673T ATE184485T1 AT E184485 T1 ATE184485 T1 AT E184485T1 AT 94402673 T AT94402673 T AT 94402673T AT 94402673 T AT94402673 T AT 94402673T AT E184485 T1 ATE184485 T1 AT E184485T1
Authority
AT
Austria
Prior art keywords
heteroaryl
aryl
treatment
piperazinylbutyl
production
Prior art date
Application number
AT94402673T
Other languages
English (en)
Inventor
Constansa Jordi Frigola
Vidal Ramon Merce
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of ATE184485T1 publication Critical patent/ATE184485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
AT94402673T 1993-11-25 1994-11-23 Verwendung der 1-4-4-aryl(oder heteroaryl)-1- piperazinylbutyl-1h-azol-derivate zur herstellung von arzneimitteln zur behandlung der störungen der magensekretion ATE184485T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9314102A FR2712808B1 (fr) 1993-11-25 1993-11-25 Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .

Publications (1)

Publication Number Publication Date
ATE184485T1 true ATE184485T1 (de) 1999-10-15

Family

ID=9453220

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94402673T ATE184485T1 (de) 1993-11-25 1994-11-23 Verwendung der 1-4-4-aryl(oder heteroaryl)-1- piperazinylbutyl-1h-azol-derivate zur herstellung von arzneimitteln zur behandlung der störungen der magensekretion

Country Status (10)

Country Link
US (1) US5532234A (de)
EP (1) EP0655248B1 (de)
JP (1) JPH07242626A (de)
AT (1) ATE184485T1 (de)
AU (1) AU674458B2 (de)
CA (1) CA2136661A1 (de)
DE (1) DE69420679D1 (de)
ES (1) ES2089974B1 (de)
FR (1) FR2712808B1 (de)
ZA (1) ZA949332B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633377A (en) * 1990-12-28 1997-05-27 Neurogen Corporation 4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligands
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
WO1997003058A1 (en) * 1995-07-07 1997-01-30 Taisho Pharmaceutical Co., Ltd. 4-alkylthiazoline derivatives
FR2763950B1 (fr) * 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
AU4005300A (en) * 1999-03-03 2000-09-21 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
RU2317988C2 (ru) 2000-08-14 2008-02-27 Орто-Макнейл Фармасьютикал, Инк. Замещенные пиразолы, фармацевтическая композиция на их основе, применение фармацевтической композиции и способ ингибирования активности катепсина s
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
PT1309592E (pt) 2000-08-14 2006-07-31 Ortho Mcneil Pharm Inc Pirazoles substituidos
AU2001281255B2 (en) 2000-08-14 2006-07-20 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazoles
CN1642973A (zh) 2000-09-06 2005-07-20 奥索-麦克尼尔药品公司 治疗变态反应的方法
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
WO2014079154A1 (zh) * 2012-11-26 2014-05-30 辽宁贝雷生物制药有限公司 苯并五元氮杂环基哌啶或哌嗪衍生物及其制备方法和药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion

Also Published As

Publication number Publication date
FR2712808A1 (fr) 1995-06-02
AU674458B2 (en) 1996-12-19
ES2089974B1 (es) 1997-03-16
EP0655248B1 (de) 1999-09-15
ES2089974A1 (es) 1996-10-01
EP0655248A1 (de) 1995-05-31
AU7900794A (en) 1995-06-01
US5532234A (en) 1996-07-02
ZA949332B (en) 1995-11-14
JPH07242626A (ja) 1995-09-19
FR2712808B1 (fr) 1996-02-16
CA2136661A1 (fr) 1995-05-26
DE69420679D1 (de) 1999-10-21

Similar Documents

Publication Publication Date Title
ATE108453T1 (de) Benzopyridopiperidin, -piperidyliden und - piperazin-verbindungen, zusammensetzungen, methoden zur herstellung und verwendung.
FI942074A0 (fi) nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
DE69004837D1 (de) Verwendung von 5-Methyltetrahydrofolsäure, 5-Formyltetrahydrofolsäure sowie deren pharmazeutisch geeigneten Salzen zur Herstellung von Arzneimitteln mit gesteuerter Freigabe und wirksam in der Therapie organisch mentaler Störungen sowie die entsprechenden Arzneimittel.
BR9406940A (pt) Magnésio-omeprazol processo para a preparação de magnésio-omeprazol composição farmacêutica formulação farmacêutica para a administração oral forumulação de tablete uso do magnesio-omeprazol processo para a inibição da secreção de ácido gástrico em mamiferos e no homem e processo para o tratamento das doenças relacionadas com o ácido gastrico em mamiferos e no homem
DE59402222D1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE59310327D1 (de) Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
ES2060951T5 (es) Azaindenos.
DE69420679D1 (de) Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
ATE62683T1 (de) Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
NO933200L (no) Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
DE68924006D1 (de) Pharmazeutische Zusammensetzungen mit Eierschalenbestandteilen und ihre Herstellung und Verwendung.
BR9611871B1 (pt) diaminopirimidinas, compostos intermediários para a sìntese das mesmas, bem como medicamento que as contém.
ATE231849T1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
AR004378A1 (es) Utilizacion de los derivados de 1-{4-(4-aril(o heteroaril)-1-piperazinil)- butil}-1h-azol para la preparacion de un medicamento destinado al tratamientode los trastornos obsesivo-compulsivos, la apnea del sueno, las disfunciones sexuales, la emesis y el mareo en los mamiferos, incluido el hombre.
DE50006603D1 (de) Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
ATE124039T1 (de) Durch azetidine substituierte derivate von pyridon-carboxylsäure, ihre herstellung und verwendung als arzneimittel.
ATE380789T1 (de) Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie
EP0535250A4 (en) Novel compounds and use thereof as medicine
DE69531554D1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
ATE112276T1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE13669T1 (de) 4-aryloxy-3-phenylpiperidin-derivate, zwischenprodukte, verfahren zur herstellung solcher verbindungen und ihre verwendung als arzneimittel.
ATE69223T1 (de) Oxolabdane, verfahren zu deren herstellung und deren verwendung als arzneimittel.